A rat model presenting eosinophilia in the airways, lung eosinophil activation, and pulmonary hyperreactivity

Experimental Lung Research

Volumn 25, Issue 4, 1999, Pages 303-316

  Carvalho, Celso ^a   Jancar, Sonia ^b   Mariano, Mario ^b   Sirois, Pierre ^a,c  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Animal model; Asthma; Eosinophil peroxidase; EPO; Lung eosinophilia; Lung hypersensitivity; Pulmonary hyperreactivity

Indexed keywords

PEROXIDASE; PROSTAGLANDIN E2; SEROTONIN; THROMBOXANE B2;

AIRWAY CONSTRICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EXPERIMENTAL MODEL; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; LOEFFLER PNEUMONIA; LUNG PRESSURE; MEAN ARTERIAL PRESSURE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; DINOPROSTONE; DISEASE MODELS, ANIMAL; EOSINOPHIL PEROXIDASE; EOSINOPHILS; IMMUNIZATION; OVALBUMIN; PEROXIDASES; PULMONARY EOSINOPHILIA; RATS; RATS, WISTAR; RESPIRATORY FUNCTION TESTS; RESPIRATORY HYPERSENSITIVITY; SEROTONIN; THROMBOXANE B2;

EID: 0033063608     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/019021499270213     Document Type: Article

References (40)

1. 1. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH, Holgate ST: Mucosal inflammation in asthma. Am Rev Resp Dis. 1990;142:434-457.
2. 2. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB: Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Resp Dis. 1988;137:62-69.
3. 3. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D: Cytotoxic properties of eosinophils major basic protein. J Immunol. 1979;123:2925-2927.
4. 4. Frigas E, Loegering DA, Gleich GJ: Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest. 1980;42:35-43.
5. 5. Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM: Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: role of the epithelium. Am Rev Resp Dis. 1988;138:685-688.
6. 6. Cartier A, Thomson NC, Frith PA, Roberts R, Hargreave FE: Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in the airway caliber. J Allergy Clin Immunol. 1982;70:170-177.
7. 7. Hutson PA, Church MK, Clay TP, Miller P, Holgate ST: Early and late-phase bronchoconstriction after challenge of nonanesthetized guinea pigs. 1. The association of disordered airway physiology to leukocyte infiltration. Am Rev Resp Dis. 1988;137:548-557.
8. 4 in allergen-induced increases in airway smooth muscle in the rat. Am Rev Resp Dis. 1993;148:413-417.
9. 9. O'Byrne PM, Dolovich J, Hargreave FE: Late asthmatic response. Am Rev Resp Dis. 1987;136:740-751.
10. 10. Pauwels R: The pharmacology of airway hyperresponsiveness and inflammation. Lung. 1990;168):221-229.
11. 11. Metzger WJ: Late-phase asthma in an allergic rabbit model. In: Dorsch W, ed. Late-Phase Allergic Reactions. Boca Raton, FL: CRC Press; 1990:347-362.
12. 12. Elwood W, Lötvall JO, Barnes PJ, Chung KF: Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively Brown-Norway rats. J Allergy Clin Immunol. 1991;88:951-960.
13. 13. Maghni K, Blanchette F, Sirois P: Induction of lung eosinophilia in guinea-pig following injection of Sephadex beads. Inflammation. 1993;17:537-550.
14. 14. Anderson P: Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs. Pattern of response in relation to immunization regimen. Allergy. 1980;35:65-71.
15. 15. Desquand S, Tothhut B, Vargaftig BB: Role of immunoglobulins G1 and G2 in anaphylatic shock in the guinea-pig. Int Arch Allergy Appl Immunol. 1990;93:184-191.
16. 16. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG: Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med. 1989;320:271-277.
17. 17. Pretolani M, Vargaftig BB: From lung hypersensitivity to bronchial hyperreactivity. What we can learn from studies on animal models? Biochem Pharmacol. 1993;45:1306-1310.
18. 18. Facincone S, de Siqueira ALP, Jancar S, Russo M, Barbuto JAM, Mariano: A novel murine model of late-phase reaction of immediate hypersensitivity. Mediators Inflam. 1997;6:127-133.
19. 19. de Siqueira ALP, Russo M, Steil AA, Facincone S, Mariano M, Jancar S: A new murine model of pulmonary eosinophilic hypersensitivity: contribution to experimental asthma. J Allergy Clin Immunol. 1997;100:383-388.
20. 20. Titus RG, Chiller JM: A simple and effective method to assess murine model of late-phase reaction of immediate hypersensitivity to proteins. J Immunol Methods. 1981;45:65-78.
21. 21. Strath M, Warren DJ, Sanderson CJ: Detection of eosinophils using an eosinophil peroxidase assay for eosinophil differentiation factors. J Immunol Methods. 1985;83:209-215.
22. 22. Pradelles P, Grassi J, Maclouf J: Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem. 1985;57:1170-1171.
23. 23. Milne AAY, Piper P: The effects of two anti-CD18 antibodies on antigen-induced airway hyperresponsiveness and leukocyte accumulation in the guinea pig. Am J Respir Cell Mol Biol. 1994;11:337-343.
24. 24. Van De Graaf EA, Out TA, Roos CM, Jansen HM: Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Am Rev Resp Dis. 1991;143:362-368.
25. 25. Gibson PG, Denburg J, Dolovich J, Ramsdale EH, Hargreave FE: Chronic cough: eosinophilic bronchitis without asthma. Lancet. 1989;1:1346-1348.
26. 26. Kips JC, Cuvelier CA, Pauwels RA: Effect of acute and chronic antigen inhalation on airway morphology and responsiveness in actively sensitized rats. Am Rev Resp Dis. 1992;145:1306-1310.
27. 27. Pretolani M, Ruffie C. Joseph D, Campos MG, Church MK, Lefort J, Vargaftig BB: Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am J Respir Crit Care Med. 1994;149:1167-1174.
28. 28. Gundel RH, Gerritsen ME, Gleich GJ, Wegner CD: Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol. 1990;68:779-786.
29. 29. Myou S, Fujimura M, Mishi K, Ohka T, Matsuda T: Inhibitory effect of a selective thromboxane synthetase inhibitor, OKY-046, on a acetaldehyde-induced bronchoconstriction in asthmatic patients. Chest. 1994;106:1414-1418.
30. 30. Saito M, Fujimura M, Mizuhashi K, Shintani N, Matsuda T: Effects of aerosol administration of a thromboxane receptor antagonist (S-1452) on experimental asthma in guinea pigs. Allergy. 1994;49:680-684.
31. 31. Jones GL, Saroca HG, Watson RM, O'Byrne PM: Effect of an inhaled thromboxane mimetic (U46619) on airway function. Am Rev Resp Dis. 1992;145:1270-1274.
32. 32. Piacentini GL, Kaline MA: The potential roles of leukotrienes in bronchial asthma. Am Rev Resp Dis. 1991;143:S96-S99.
33. 33. Liu MC, Hubbard WC, Proud D, Stealey B, Galli S, Kagey-Sobotka A, Bleecker ER, Lichtenstein LM: Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in asthmatics: cellular, mediator, and permeability changes. Am Rev Resp Dis. 1991;144:51-58.
34. 34. Vignola AM, Chanez P, Campbell AM, Bousquet J, Michel FB, Godard P: Functional and phenotypic characteristics of bronchial epithelial cells obtained by brushing from asthmatics and normal subjects. Allergy. 1993;48:32-38.
35. 2. In: Samuellsson B and Paoletti R., eds. Adv Prostaglandin Thromboxane Res. 1976;1:461-475.
36. 2 on allergic-induced asthma. Am Rev Resp Dis. 1993;148:87-90.
37. 37. Russo M, Jancar S, de Siqueira ALP, Mengel J, Gomes E, Ficker SM, Faria AMC: Oral tolerance prevents the development of experimental asthma. Immunol Lett. 1997;61:15-23.
38. 38. Stavnezer J: Immunoglobulin class switching. Curr Opin Immunol. 1996;8:199-205.
39. 39. Guery J-C, Galbiati F, Smiroldo S, Adorini L: Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulins-deficient BALB/c mice. J Exp Med. 1996;83:485-497.
40. 40. Kurup VP, Choi H, Murali PS, Resnick A, Fink JN, Coffman RL. Role of particulate antigens of Aspergillus in murine eosinophilia. Int Arch Allergy Immunol. 1997;112:270-278.